Malaria Vaccine
Immune evasion by malaria parasites reviewed
Published in Vaccine Weekly, August 10th, 2005
According to a study from Japan, "Malaria is one of the most life-threatening infectious diseases worldwide. Specific immunity to natural infection is acquired slowly despite a high degree of repeated exposure and rarely continues for a long time even in endemic areas. Malaria parasites have evolved to acquire diverse immune evasion mechanisms that evoke poor immune responses and allow infection of individuals previously exposed. The shrewd schema of malaria parasites also hampers the development of effective vaccines....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-08-10)
More Articles from Vaccine Weekly
- Breast Cancer Vaccine
A Tat fusion protein-based tumor vaccine for breast cancer developed - Chickenpox Vaccine
Oka/GSK attenuated varicella vaccine prevents chickenpox in clinical practice - HIV/AIDS Vaccine
Cross-reactivity of anti-HIV immune responses of major HIV-1 clades reported - Monoclonal Antibodies
Plant biopharming of monoclonal antibodies reviewed - Vector Development
Intracarotid delivery of oncolytic HSV vector to brain cancer reported - Animal Models
Nonhuman primates are models for hematology, immunology, and virology studies - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
